Google DeepMind CEO says 2025's the year we start popping pills AI helped invent
Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...
The Lancet6h
Reporting discrepancy of alcohol intake affecting estimated prevalence of MetALD and ALD
For several decades, the prevalence of steatotic liver disease (SLD) has been steadily increasing.1 Alterations in hepatic ...
There is a 'valley of death' in European research and innovation, says CEO of Novo Nordisk Foundation
There is a 'valley of death' in European research and innovation, says CEO of Novo Nordisk Foundation ...
4NVO : Decoding Novo Nordisk's Options Activity: What's...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a new study finds
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have other untapped potentials to reduce health risks.
World’s largest offshore wind farm maker Orsted takes fresh $1.7 billion write-down in the U.S. as its Trump nightmare begins
Danish offshore wind giant Orsted faced a fresh stock market hammering on Tuesday after the group announced a new ...
The race for the next Ozempic is on
Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...
Armed robbery in Revesby23h
Research Probes Flu Resistance Development
An international project into flu immunity could help develop better medications and vaccines to prevent severe disease.Imperial researchers will ...
greenqueen23h
These Alternative Food Coloring Startups Set To Win Big With FDA’s Ban on Red Dye No. 3
The US FDA has banned Red Dye No. 3 after its link with cancer in rats, presenting an opportunity to alternative food ...